Abstract
Rational pharmacotherapy helping chronic psychiatric patients in the difficult process of reintegration into the community is an important prerequisite of successful rehabilitation. Results of a survey conducted at the opening of a rehabilitation facility in Hong Kong revealed a number of illogicalities in prescription patterns. Frequently encountered faulty treatment decisions incompatible with the recommendations of modern literature included polypharmacy, higher than necessary doses of anticholinergic antiparkinsonian agents and giving psychotropic drugs in inconveniently divided doses. With the newly emerging subspecialty of rehabilitation-community psychiatry in Hong Kong, it is expected that large numbers of chronically hospitalized patients will enter rehabilitation programmes. The present survey indicated that it is imperative to pay continued attention to their medication status.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Michel K, Kolakowska T (1981) A survey of prescribing psychotropic drugs in two psychiatric hospitals. Br J Psychiatry 138: 217–221
Edwards S, Kumar V (1984) A survey of prescribing of psychotropic drugs in a Birmingham hospital. Br J Psychiatry 145: 502–507
Wilson WH, Ban TA, Guy W (1985) Pharmacotherapy of chronic hospitalized schizophrenics: prescription practices. Neuropsychobiology 14: 75–82
Muijen M, Silverstone T (1987) Comparative hospital survey of psychotropic drug prescribing. Br J Psychiatry 150: 501–504
Clark AF, Holden NL (1987) The persistence of prescribing habits: a survey and follow-up of prescribing to chronic hosptial in-patients. Br J Psychiatry 150: 88–91
Morgan R, Gopalaswamy AK (1984) Psychotropic drugs: another survey of prescribing patterns Br J Psychiatry 144: 298–302
Tang W, Yao X, Zheng Z (1994) Rehabilitative effect of music therapy for residual schizophrenia. Br J Psychiatry 165 [Suppl 24]: 38–44
Jin Z (1994) Effect of an open-door policy combined with a structured activity programme on the residual symptoms of schizophrenic in-patients. Br J Psychiatry 165 [Suppl 24]:52–57
Zhang M, Wang M, Li J, Phillips MR (1994) Randomized-control trial of family intervention for 78 first-episode schizophrenic patients. Br J Psychiatry 165 [Suppl 24]: 96–102
Johnson DAW (1985) Antipsychotic medication: clinical guidelines for maintenance therapy. J Clin Psychiatry 46: 6–15
Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 45: 79–91
Leblanc G, Cormier H, Gagne MA, Vaillancourt S (1994) Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses. Can J Psychiatry 39: 223–229
Bollini P, Pampallona S, Orza MJ, Adams ME, et al (1994) Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials. Psychol Med 24: 307–316
Lo WH (1986) Changing scenes in the delivery of mental health care. In: Khoo TP (ed) Mental health in Hong Kong. Mental Health Association of Hong Kong. Hong Kong, pp 24–32
Davis JM (1976) Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 33: 858–861
Wressell SE, Tyrer SP, Bernet TP (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital survey. Br J Psychiatry 157: 101–106
World Health Organization (1993) ICD-10 Chapter V. Diagnostic Criteria for Research. WHO, Geneva
Faraone SV, Green AI, Brown W, Yin P, et al (1989) Neuroleptic dose reduction in persistently psychotic patients. Hosp Community Psychiatry 40: 1193–1195
Smith RC (1994) Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients. Arch Gen Psychiatry 51: 427–429
Chiu HFK, Shum PS, Lam CW (1991) Psychotropic drug prescribing to chronic schizophrenics in a Hong Kong hospital. Int J Soc Psychiatry 37: 187–191
Chiu HFK, Lee S, Leung CM, Wing YK (1992) Neuroleptic prescription for Chinese schizophrenics in Hong Kong. Aust N Z J Psychiatry 26: 262–264
Lin KM, Finder E (1983) Neuroleptic dosage for Asians. Am J Psychiatry 140: 490–491
Rosenblat R, Tang SW (1987) Do Oriental psychiatric patients receive different dosages of psychotropic medication when compared with Occidentals. Can J Psychiatry 32: 270–274
Lin KM, Poland RE, Nuccio I, Matsuda K et al (1989) A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am J Psychiatry 146: 1307–1311
Inderbitzin LB, Lewine RRJ, Scheller-Gilkey G, Swofforf CD, et al (1994) A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. Am J Psychiatry 151: 1753–1759
Gerlach J (1991) Attitude towards the use of depot antipsychotics in several European countries. In: Wistedt B, Gerlach J (eds) Depot antipsychotics in chronic schizophrenia. Excerpta Medica, Amsterdam, pp 87–97
Johnson DAW (1991) Depot therapy—advantages, disadvantages and issues of dose. In: Wistedt B, Gerlach J (eds) Depot antipsychotics in chronic schizophrenia. Excerpta Medica, Amsterdam, pp 4–17
White E, Cheung P, Silverstone T (1993) Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 8: 119–122
Chen CN, Wong J, Lee N et al (1993) The Shatin community mental health survey in Hong Kong: II. Major findings. Arch Gen Psychiatry 50: 125–133
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ungvari, G.S., Pang, A.H.T., Chiu, H.F.K. et al. Psychotropic drug prescription in rehabilitation. Soc Psychiatry Psychiatr Epidemiol 31, 288–291 (1996). https://doi.org/10.1007/BF00787922
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00787922